Neoadjuvant Therapy of HAIC（GEMOX） Combined With Adebrelimab and Lenvatinib for Resectable Intrahepatic Cholangiocarcinoma With High-risk Recurrence Factors

NCT06208462 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

33

Enrollment

OTHER

Sponsor class

Conditions

Intrahepatic Cholangiocarcinoma

Interventions

DRUG: Adebrelimab
DRUG: Lenvatinib
DRUG: Gemcitabine
DRUG: Oxaliplatin

Sponsor

The First Affiliated Hospital with Nanjing Medical University

Collaborators

[object Object]